Investigation and management of heritable thrombophilia
- 1 September 2001
- journal article
- guideline
- Published by Wiley in British Journal of Haematology
- Vol. 114 (3) , 512-528
- https://doi.org/10.1046/j.1365-2141.2001.02981.x
Abstract
No abstract availableKeywords
This publication has 152 references indexed in Scilit:
- Practical strategies for hormone replacement therapy and risk of venous thromboembolismBJOG: An International Journal of Obstetrics and Gynaecology, 1998
- Risk of Stroke in Young Women and Two Prothrombotic Mutations: Factor V Leiden and Prothrombin Gene Variant (G20210A)Stroke, 1998
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- Resistance to activated protein C in healthy women taking oral contraceptivesBritish Journal of Haematology, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Influence of demographic factors on antithrombin III activity in a healthy populationBritish Journal of Haematology, 1993
- Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. Maternal and Neonatal haemostasis Working Party of the Haemostasis and Thrombosis Task.Journal of Clinical Pathology, 1993
- Absence of Thrombosis in Subjects with Heterozygous Protein C DeficiencyNew England Journal of Medicine, 1987